FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/31/2025
Back to search
Official data from USPTO
PRIMOPUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
PRIMOPUS
ST13
US500000079373510Class
1, 5, 40, 42
Filing
79373510
Registration
7741406
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
04/03/2026
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 40, 42
Filing date
12/09/2022
Registration date
04/01/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/01/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
VO, KOMAL MAKHDOOM
Law office
O10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Imaginarium Future Limited
Representatives
Joseph G. Chu JCIP
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biological products for use in industryscience and scientific researchchemical preparations for use in industrybiochemical preparations for scientific purposesbiological preparations for use in industry and science; diagnostic agents and reagents for use in industrial usefor use in the manufacture of pharmaceuticalsin science and research; chemical and biological products and solutions in the nature of chemicalsFmoc amino acids and phosphoramidites for use in science and in the manufacture of pharmaceuticals
Class 5
Pharmaceuticalspharmaceutical preparations and substances for the prevention and treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricimmune systemocularbacteria-based related diseases and disordersanti-infective preparationsantiviral preparationsantibioticsantifungal preparationsvaccinessanitary preparations for medical use; chemicalbiochemical and biological products namely chemicalbiochemical and biological reagents for medical use; agrochemical preparations in the nature of fungicides and herbicides
Class 40
Custom manufacture of pharmaceuticals and of pharmaceutical formulations; custom manufacture of pharmaceuticals and biopharmaceuticalsactive pharmaceuticals
Class 42
Research and development of pharmaceuticals and biopharmaceuticalsactive pharmaceuticals for the prevention and treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatricimmune systemocularbacteria-based related diseases and disordersanti-infective preparationsantiviral preparationsantibioticsantifungal preparationsvaccines
Publications
History of USPTO decisions and trademark events.
39 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/09/2025
FIMP
FINAL DISPOSITION PROCESSED
10/09/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/01/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/01/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
04/01/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/28/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/11/2025
PUBO
PUBLISHED FOR OPPOSITION
02/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/05/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/03/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/03/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/22/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/16/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/16/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/16/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/17/2024
GNFR
FINAL REFUSAL E-MAILED
07/17/2024
CNFR
FINAL REFUSAL WRITTEN
07/17/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/17/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/17/2024
ALIE
ASSIGNED TO LIE
06/17/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/31/2024
PETG
PETITION TO REVIVE-GRANTED
05/31/2024
PROA
TEAS PETITION TO REVIVE RECEIVED
05/31/2024
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
04/12/2024
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
04/12/2024
ATRV
ATTORNEY REVIEW COMPLETED
10/31/2023
RFNT
REFUSAL PROCESSED BY IB
10/25/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/29/2023
RFRR
REFUSAL PROCESSED BY MPU
09/29/2023
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
09/29/2023
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
09/24/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/16/2023
CNRT
NON-FINAL ACTION WRITTEN
09/15/2023
DOCK
ASSIGNED TO EXAMINER
09/15/2023
MAFR
APPLICATION FILING RECEIPT MAILED
07/11/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/07/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/06/2023
Continuous trademark protection
Get notified about every new filing that threatens PRIMOPUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.